Sabo E - Search Results

1

The effect of antiviral therapy on t(14;18) translocation and immunoglobulin gene rearrangement in patients with chronic hepatitis C virus infection.

Zuckerman E, Zuckerman T, Sahar D, Streichman S, Attias D, Sabo E, Yeshurun D, Rowe JM. Zuckerman E, et al. Among authors: sabo e. Blood. 2001 Mar 15;97(6):1555-9. doi: 10.1182/blood.v97.6.1555. Blood. 2001. PMID: 11238090 Free article.

2

Antiviral treatment down-regulates peripheral B-cell CD81 expression and CD5 expansion in chronic hepatitis C virus infection.

Zuckerman E, Kessel A, Slobodin G, Sabo E, Yeshurun D, Toubi E. Zuckerman E, et al. Among authors: sabo e. J Virol. 2003 Oct;77(19):10432-6. doi: 10.1128/jvi.77.19.10432-10436.2003. J Virol. 2003. PMID: 12970428 Free PMC article.

3

Treatment of refractory, symptomatic, hepatitis C virus related mixed cryoglobulinemia with ribavirin and interferon-alpha.

Zuckerman E, Keren D, Slobodin G, Rosner I, Rozenbaum M, Toubi E, Sabo E, Tsykounov I, Naschitz JE, Yeshurun D. Zuckerman E, et al. Among authors: sabo e. J Rheumatol. 2000 Sep;27(9):2172-8. J Rheumatol. 2000. PMID: 10990230 Clinical Trial.

4

bcl-2 and immunoglobulin gene rearrangement in patients with hepatitis C virus infection.

Zuckerman E, Zuckerman T, Sahar D, Streichman S, Attias D, Sabo E, Yeshurun D, Rowe J. Zuckerman E, et al. Among authors: sabo e. Br J Haematol. 2001 Feb;112(2):364-9. doi: 10.1046/j.1365-2141.2001.02573.x. Br J Haematol. 2001. PMID: 11167830 Free article.

5

Enhanced apoptosis of peripheral CD5-negative B lymphocytes from chronically hepatitis C virus-infected patients: reversal after antiviral treatment.

Toubi E, Kessel A, Peri R, Shmuel Z, Bamberger E, Sabo E, Zuckerman E. Toubi E, et al. Among authors: sabo e. J Virol. 2004 Oct;78(20):11379-84. doi: 10.1128/JVI.78.20.11379-11384.2004. J Virol. 2004. PMID: 15452259 Free PMC article.

6

Enhanced peripheral T-cell apoptosis in chronic hepatitis C virus infection: association with liver disease severity.

Toubi E, Kessel A, Goldstein L, Slobodin G, Sabo E, Shmuel Z, Zuckerman E. Toubi E, et al. Among authors: sabo e. J Hepatol. 2001 Dec;35(6):774-80. doi: 10.1016/s0168-8278(01)00207-0. J Hepatol. 2001. PMID: 11738105

7

Peripheral B-cell CD5 expansion and CD81 overexpression and their association with disease severity and autoimmune markers in chronic hepatitis C virus infection.

Zuckerman E, Slobodin G, Kessel A, Sabo E, Yeshurun D, Halas K, Toubi E. Zuckerman E, et al. Among authors: sabo e. Clin Exp Immunol. 2002 May;128(2):353-8. doi: 10.1046/j.1365-2249.2002.01844.x. Clin Exp Immunol. 2002. PMID: 11985527 Free PMC article.

8

Increased thromboembolic incidence in anti-cardiolipin-positive patients with malignancy.

Zuckerman E, Toubi E, Golan TD, Rosenvald-Zuckerman T, Sabo E, Shmuel Z, Yeshurun D. Zuckerman E, et al. Among authors: sabo e. Br J Cancer. 1995 Aug;72(2):447-51. doi: 10.1038/bjc.1995.353. Br J Cancer. 1995. PMID: 7640230 Free PMC article.

9

Cancer antigen 125: a sensitive marker of ascites in patients with liver cirrhosis.

Zuckerman E, Lanir A, Sabo E, Rosenvald-Zuckerman T, Matter I, Yeshurun D, Eldar S. Zuckerman E, et al. Among authors: sabo e. Am J Gastroenterol. 1999 Jun;94(6):1613-8. doi: 10.1111/j.1572-0241.1999.01152.x. Am J Gastroenterol. 1999. PMID: 10364033

10

Anticardiolipin antibodies and acute myocardial infarction in non-systemic lupus erythmatosus patients: a controlled prospective study.

Zuckerman E, Toubi E, Shiran A, Sabo E, Shmuel Z, Golan TD, Abinader E, Yeshurun D. Zuckerman E, et al. Among authors: sabo e. Am J Med. 1996 Oct;101(4):381-6. doi: 10.1016/S0002-9343(96)00226-4. Am J Med. 1996. PMID: 8873508

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

324 results

Search Page

Filters